• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

全国、州和地方青少年(13-17 岁)疫苗接种覆盖率——美国,2009 年。

National, state, and local area vaccination coverage among adolescents aged 13-17 years --- United States, 2009.

出版信息

MMWR Morb Mortal Wkly Rep. 2010 Aug 20;59(32):1018-23.

PMID:20724968
Abstract

The Advisory Committee for Immunization Practices (ACIP) recommends that adolescents routinely receive the following vaccines: meningococcal conjugate (MenACWY, 1 dose); tetanus, diphtheria, acellular pertussis (Tdap, 1 dose); and (for females) human papillomavirus (HPV, 3 doses). Adolescents also should receive the following recommended vaccinations they missed during childhood: measles, mumps, rubella (MMR, 2 doses); hepatitis B (HepB, 3 doses); and varicella (VAR, 2 doses). Since 2006, CDC has conducted the National Immunization Survey--Teen (NIS-Teen) to estimate vaccination coverage among adolescents aged 13-17 years. This report summarizes results from 2009 NIS-Teen and updates data from 2008 NIS-Teen. Comparing 2009 with 2008, vaccination coverage among adolescents for the three routinely administered adolescent vaccines increased for Tdap (from 40.8% to 55.6%), MenACWY (from 41.8% to 53.6%), >or=1 dose of HPV (from 37.2% to 44.3%), and >or=3 doses of HPV (from 17.9% to 26.7%). Vaccination coverage varied widely among states; four states (Connecticut, Massachusetts, New Hampshire, and Rhode Island) had coverage of >60% for all three of the routinely administered adolescent vaccines (Tdap, MenACWY, and HPV). Nationally, Healthy People 2010 vaccination objectives of 90% coverage among adolescents aged 13-15 years were met for >or=3 doses of HepB and >or=1 dose of VAR. Coverage with routine adolescent vaccines is increasing; however, more effort, including identification and dissemination of successful state-based practices, is needed to continue to increase the number of adolescents vaccinated according to ACIP recommendations.

摘要

免疫实践咨询委员会(ACIP)建议青少年定期接种以下疫苗:脑膜炎球菌结合疫苗(MenACWY,1 剂);破伤风、白喉、无细胞百日咳(Tdap,1 剂);和(女性)人乳头瘤病毒(HPV,3 剂)。青少年还应接种以下在儿童时期错过的推荐疫苗:麻疹、腮腺炎、风疹(MMR,2 剂);乙型肝炎(HepB,3 剂);和水痘(VAR,2 剂)。自 2006 年以来,CDC 开展了全国青少年免疫调查(NIS-Teen),以估计 13-17 岁青少年的疫苗接种率。本报告总结了 2009 年 NIS-Teen 的结果,并更新了 2008 年 NIS-Teen 的数据。与 2008 年相比,青少年三种常规接种疫苗的接种率均有所提高,Tdap(从 40.8%增加到 55.6%)、MenACWY(从 41.8%增加到 53.6%)、>或=1 剂 HPV(从 37.2%增加到 44.3%)和>或=3 剂 HPV(从 17.9%增加到 26.7%)。各州之间的疫苗接种率差异很大;有四个州(康涅狄格州、马萨诸塞州、新罕布什尔州和罗得岛州)对所有三种常规接种疫苗(Tdap、MenACWY 和 HPV)的覆盖率均超过 60%。在全国范围内,13-15 岁青少年中 90%的 2010 年健康人疫苗接种目标达到了 HepB 的>或=3 剂和 VAR 的>或=1 剂。常规青少年疫苗的接种率正在上升;然而,需要更多的努力,包括确定和传播成功的州级实践,以继续按照 ACIP 的建议增加接种疫苗的青少年人数。

相似文献

1
National, state, and local area vaccination coverage among adolescents aged 13-17 years --- United States, 2009.全国、州和地方青少年(13-17 岁)疫苗接种覆盖率——美国,2009 年。
MMWR Morb Mortal Wkly Rep. 2010 Aug 20;59(32):1018-23.
2
National and state vaccination coverage among adolescents aged 13 through 17 years--United States, 2010.全国和各州青少年(13-17 岁)疫苗接种覆盖率——美国,2010 年。
MMWR Morb Mortal Wkly Rep. 2011 Aug 26;60(33):1117-23.
3
National, state, and local area vaccination coverage among adolescents aged 13-17 years--United States, 2008.2008年美国13至17岁青少年的全国、州和地方疫苗接种覆盖率
MMWR Morb Mortal Wkly Rep. 2009 Sep 18;58(36):997-1001.
4
Vaccination coverage among adolescents aged 13-17 years - United States, 2007.2007年美国13至17岁青少年的疫苗接种覆盖率
MMWR Morb Mortal Wkly Rep. 2008 Oct 10;57(40):1100-3.
5
National and state vaccination coverage among adolescents aged 13-17 years--United States, 2011.全国和各州青少年(13-17 岁)疫苗接种覆盖率——美国,2011 年。
MMWR Morb Mortal Wkly Rep. 2012 Aug 31;61(34):671-7.
6
National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13-17 Years - United States, 2017.国家、地区、州和选定的局部地区 13-17 岁青少年疫苗接种覆盖率 - 美国,2017 年。
MMWR Morb Mortal Wkly Rep. 2018 Aug 24;67(33):909-917. doi: 10.15585/mmwr.mm6733a1.
7
National vaccination coverage among adolescents aged 13-17 years--United States, 2006.2006年美国13至17岁青少年的国家疫苗接种覆盖率
MMWR Morb Mortal Wkly Rep. 2007 Aug 31;56(34):885-8.
8
National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13-17 Years - United States, 2020.全国、地区、州和选定的局部地区 13-17 岁青少年疫苗接种覆盖率 - 美国,2020 年。
MMWR Morb Mortal Wkly Rep. 2021 Sep 3;70(35):1183-1190. doi: 10.15585/mmwr.mm7035a1.
9
National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13-17 Years - United States, 2016.2016年美国13至17岁青少年的全国、地区、州及部分局部地区疫苗接种覆盖率
MMWR Morb Mortal Wkly Rep. 2017 Aug 25;66(33):874-882. doi: 10.15585/mmwr.mm6633a2.
10
National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13-17 Years - United States, 2015.国家、地区、州和选定的局部地区 13-17 岁青少年疫苗接种覆盖率 - 美国,2015 年。
MMWR Morb Mortal Wkly Rep. 2016 Aug 26;65(33):850-8. doi: 10.15585/mmwr.mm6533a4.

引用本文的文献

1
Characterization of HPV Vaccination Uptake by Birth Cohorts in a Healthcare System in Pennsylvania: A Post-COVID-19 Pandemic Historical Cohort Assessment.宾夕法尼亚州一个医疗系统中按出生队列划分的HPV疫苗接种情况特征:COVID-19大流行后的历史性队列评估
Cancer Control. 2025 Jan-Dec;32:10732748251359401. doi: 10.1177/10732748251359401. Epub 2025 Jul 19.
2
Barriers to Human Papillomavirus Vaccination Initiation and Completion among Adults Aged 18-26 Years in a Large Healthcare System.大型医疗系统中18至26岁成年人启动和完成人乳头瘤病毒疫苗接种的障碍
Cancers (Basel). 2023 Aug 24;15(17):4243. doi: 10.3390/cancers15174243.
3
Descriptive epidemiology of age at HPV vaccination: Analysis using the 2020 NIS-Teen.
HPV 疫苗接种年龄的描述性流行病学:利用 2020 年 NIS-Teen 的分析。
Hum Vaccin Immunother. 2023 Dec 31;19(1):2204784. doi: 10.1080/21645515.2023.2204784.
4
Human papillomavirus vaccination coverage among sexually active young adults aged 18 to 26 at a sexually transmitted infections clinic.性传播感染门诊中 18 至 26 岁性活跃的年轻人中人类乳头瘤病毒疫苗接种率。
Int J STD AIDS. 2023 Apr;34(5):315-321. doi: 10.1177/09564624221146605. Epub 2023 Jan 19.
5
Acceptance of Human Papillomavirus Vaccination and Associated Factors among Girls in Arba Minch Town, Southern Ethiopia, 2020.2020 年,埃塞俄比亚南部阿尔巴明奇镇女孩对人乳头瘤病毒疫苗接种的接受情况及相关因素。
Infect Dis Obstet Gynecol. 2022 Dec 7;2022:7303801. doi: 10.1155/2022/7303801. eCollection 2022.
6
Assessment of Knowledge About Human Papillomavirus Vaccination Among Primary School Girls in Arba Minch Town, South Ethiopia, 2020 an Institution-Based Cross-Sectional Study.2020年埃塞俄比亚南部阿尔巴明奇镇小学女生人乳头瘤病毒疫苗接种知识评估:一项基于机构的横断面研究
Cancer Manag Res. 2022 Jul 18;14:2205-2214. doi: 10.2147/CMAR.S359413. eCollection 2022.
7
A school-based educational on-site vaccination intervention for adolescents in an urban area in Germany: feasibility and psychometric properties of instruments in a pilot study.德国城市地区针对青少年的基于学校的教育现场疫苗接种干预:一项试点研究中工具的可行性和心理测量学特性。
BMC Public Health. 2022 Jan 10;22(1):60. doi: 10.1186/s12889-021-12443-8.
8
Increasing HPV Vaccination among Low-Income, Ethnic Minority Adolescents: Effects of a Multicomponent System Intervention through a County Health Department Hotline.提高低收入、少数民族青少年的 HPV 疫苗接种率:通过县卫生部门热线实施多组分系统干预的效果。
Cancer Epidemiol Biomarkers Prev. 2022 Jan;31(1):175-182. doi: 10.1158/1055-9965.EPI-20-1578. Epub 2021 Oct 14.
9
Socioeconomic and Racial Determinants of Brachytherapy Utilization for Cervical Cancer: Concerns for Widening Disparities.社会经济和种族因素对宫颈癌近距离放疗利用的影响:对差距扩大的担忧。
JCO Oncol Pract. 2021 Dec;17(12):e1958-e1967. doi: 10.1200/OP.21.00291. Epub 2021 Sep 22.
10
Impact of disruptions and recovery for established cervical screening programs across a range of high-income country program designs, using COVID-19 as an example: A modelled analysis.以 COVID-19 为例,对一系列高收入国家不同项目设计的既定宫颈癌筛查项目中断和恢复的影响:模型分析。
Prev Med. 2021 Oct;151:106623. doi: 10.1016/j.ypmed.2021.106623. Epub 2021 May 23.